Current Assets
Raw materials
Neurocrine Biosciences Raw materials decreased by 14.0% to $30.7M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.8%, from $31.9M to $30.7M. Over 5 years (FY 2020 to FY 2025), Raw materials shows an upward trend with a 16.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2019
Last reportedQ1 2026May 5, 2026
Parent metricInventories
Metric ID:
inv_raw_materialsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.2M | $13M | $11.2M | $9.2M | $8M | $15M | $12M | $6.7M | $10.4M | $9.1M | $21.5M | $18.1M | $21.3M | $23.7M | $33.7M | $31.9M | $28M | $40.1M | $35.7M | $30.7M |
| QoQ Change | — | -8.5% | -13.8% | -17.9% | -13.0% | +87.5% | -20.0% | -44.2% | +55.2% | -12.5% | +136.3% | -15.8% | +17.7% | +11.3% | +42.2% | -5.3% | -12.2% | +43.2% | -11.0% | -14.0% |
| YoY Change | — | — | — | — | -43.7% | +15.4% | +7.1% | -27.2% | +30.0% | -39.3% | +79.2% | +170.1% | +104.8% | +160.4% | +56.7% | +76.2% | +31.5% | +69.2% | +5.9% | -3.8% |
| % of Inventories | 50.2% | 51.0% | 36.7% | 31.7% | 27.3% | 40.5% | 34.2% | 20.1% | 32.8% | 31.6% | 49.4% | 48.1% | 48.7% | 51.7% | 58.7% | 53.8% | 49.0% | 57.7% | 51.6% | 47.4% |
| Share Change | — | +0.8pp | -14.3pp | -5.0pp | -4.4pp | +13.2pp | -6.4pp | -14.1pp | +12.7pp | -1.2pp | +17.8pp | -1.3pp | +0.6pp | +3.0pp | +7.0pp | -4.9pp | -4.8pp | +8.7pp | -6.1pp | -4.1pp |
Range$6.7M – $40.1M
CAGR+17.6%
Avg YoY Growth+43.3%
Median YoY Growth+30.7%
Current Streak2 quarters decline
Raw materials at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's raw materials?
- Neurocrine Biosciences (NBIX) reported raw materials of $30.7M in Q1 2026.
- How has Neurocrine Biosciences's raw materials changed year-over-year?
- Neurocrine Biosciences's raw materials decreased by 3.8% year-over-year, from $31.9M to $30.7M.
- What is the long-term trend for Neurocrine Biosciences's raw materials?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's raw materials has grown at a 16.5% compound annual growth rate (CAGR), from $16.6M to $35.7M.